Agilent Technologies faces cyclical and structural challenges but shows potential for growth in FY 2025. See why I rate A ...

Have you assessed how the international operations of Agilent Technologies (A) performed in the quarter ended October 2024? For this scientific instrument maker, possessing an expansive global ...

I reiterate a “Buy” rating on Agilent Technologies, Inc. with a one-year target price of $150 per share, driven by strategic ...

Q4 2024 Earnings Call Transcript November 25, 2024 Agilent Technologies, Inc. beats earnings expectations. Reported EPS is $1 ...

Throughout the last three months, 4 analysts have evaluated Agilent Technologies A +0.10% Get Free Report , offering a ...

Agilent Technologies ( (A) ) has released its Q4 earnings. Here is a breakdown of the information Agilent Technologies presented to its ...

Medical equipment makers such as Agilent are seeing soft demand from early-stage biotechs, as these smaller drug development ...

In a report released yesterday, Brandon Couillard from Wells Fargo maintained a Buy rating on Agilent (A – Research Report), with a price ...

With vast potential, contribution to rare disease discovery and management, and adoption of AI, the genomic research market ...

In recent trading, Agilent Technologies Inc (A) stock price has shown some volatility, fluctuating 5.96% over the last five trades and 3.30% over the past 30 trades. This represents a notable shift ...

Agilent Technologies (NYSE:A – Get Free Report) was downgraded by stock analysts at StockNews.com from a “buy” rating to a “hold” rating in a research report issued on Tuesday.